Long-term inhaled nitric oxide plus dipyridamole for pulmonary arterial hypertension

Respiration

Volumn 72, Issue 4, 2005, Pages 419-422

  Pérez Peñate, Gregorio ^a   Navarro, Pedro Cabrera ^a   González, Miguel Ponce ^a   Gómez, Elías Górriz ^a   Duque, Juan Pulido ^a   Quintana, Antonio García ^a   Serdá, Gabriel Juliá ^a  

^a HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

Author keywords

Dipyridamole; Nitric oxide; Pulmonary hypertension

Indexed keywords

DIPYRIDAMOLE; NITRIC OXIDE; PHOSPHODIESTERASE V INHIBITOR;

ADULT; ARTICLE; CANNULA; CASE REPORT; CONGENITAL HEART DISEASE; DEVICE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FEMALE; HEMODYNAMICS; HOSPITAL ADMISSION; HUMAN; HYPOXEMIA; LONG TERM CARE; OXYGENATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VASODILATATION; WORLD HEALTH ORGANIZATION;

ADMINISTRATION, INHALATION; DIPYRIDAMOLE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MIDDLE AGED; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITORS; VASODILATION; VASODILATOR AGENTS;

EID: 23844533412     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086258     Document Type: Article

References (11)

1. Rich S: Primary Pulmonary Hypertension: Executive Summary from the World Symposium - Primary Pulmonary Hypertension 1998. Available from the World Health Organization via internet (http://www.who.int/ncd/cvd/pph.html).
2. Carvajal JA, Germain AM, Huidobro-Toro JP, et al: Molecular mechanism of cGMP-mediated smooth muscle relaxation. J Cell Physiol 2000;184:409-420.
3. Giaid A, Saleh D: Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995;333:214-221.
4. Channick R, Newhart J, Johnson W, et al: Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension.
5. Rich S, Dantzker DR, Ayres SM, et al: Primary pulmonary hypertension: A national prospective study. Ann Intern Med 1987;107:216-223.
6. Pérez-Peñate G, Julià-Serdà G, Púlido-Duque J, et al: One year continuous inhaled nitric oxide for primary pulmonary hypertension. Chest 2001;119:970-973.
7. Hopkins SR, Johnson EC, Richardson RS, et al: Effects of inhaled nitric oxide on gas exchange in lungs with shunt or poorly ventilated areas. Am J Respir Crit Care Med 1997;156: 484-491.
8. Filippov G, Bloch DB, Bloch KD: Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells. J Clin Invest 1997; 100:942-948.
9. 5 are elevated in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2001;281:1051-1057.
10. Ziegler J, Ivy DD, Wigging JW, et al. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension. Am J Respir Crit Care Med 1998;158:1388-1395.
11. Gerlach H, Pappert D, Lewandowski K, et al: Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med 1993; 19:443-449.